in a 3-year bioavailability program 14 studies in 45 healthy volunteers were carried out to differentiate between experimental lots of rifampicin ( rmp ) capsules and marketed preparations of other manufacturers with lower bioavailability than rifadin ( rfd ) , used as standard reference drug .
C0035608
rifampicin
C0699924
rifadin